[HTML][HTML] Indocyanine green-incorporating nanoparticles for cancer theranostics
Indocyanine green (ICG) is a near-infrared dye that has been used in the clinic for retinal
angiography, and defining cardiovascular and liver function for over 50 years. Recently …
angiography, and defining cardiovascular and liver function for over 50 years. Recently …
NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green
C Egloff-Juras, L Bezdetnaya, G Dolivet… - International journal of …, 2019 - Taylor & Francis
Surgery is the frontline treatment for a large number of cancers. The objective of these
excisional surgeries is the complete removal of the primary tumor with sufficient safety …
excisional surgeries is the complete removal of the primary tumor with sufficient safety …
ER-targeting PDT converts tumors into in situ therapeutic tumor vaccines
X Liu, Y Liu, X Li, J Huang, X Guo, J Zhang, Z Luo… - Acs Nano, 2022 - ACS Publications
A therapeutic tumor vaccine is a promising approach to cancer treatment. One of its
strategies is to treat patient-derived tumor cells in vitro and then administer them in vivo to …
strategies is to treat patient-derived tumor cells in vitro and then administer them in vivo to …
Quantitative assessment of nanoparticle biodistribution by fluorescence imaging, revisited
Fluorescence-based whole-body imaging is widely used in the evaluation of nanoparticles
(NPs) in small animals, often combined with quantitative analysis to indicate their …
(NPs) in small animals, often combined with quantitative analysis to indicate their …
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
PK Luo, HM Ho, MC Chiang, LA Chu… - Advanced …, 2024 - Wiley Online Library
Abstract mRNA vaccines for cancer immunotherapy are commonly delivered using lipid
nanoparticles (LNPs), which, when administered intravenously, may accumulate in the liver …
nanoparticles (LNPs), which, when administered intravenously, may accumulate in the liver …
Measuring particle size distribution by asymmetric flow field flow fractionation: a powerful method for the preclinical characterization of lipid-based nanoparticles
Particle size distribution and stability are key attributes for the evaluation of the safety and
efficacy profile of medical nanoparticles (Med-NPs). Measuring particle average size and …
efficacy profile of medical nanoparticles (Med-NPs). Measuring particle average size and …
Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis
P Wang, Y Zhang, H Lei, J Yu, Q Zhou, X Shi… - Carbohydrate …, 2023 - Elsevier
Herein, hyaluronic acid (HA) and β-cyclodextrin (β-CD) is used to form targeted drug
delivery platform HCPC/DEX NPs with previously prepared carbon dots (CDs) as cross …
delivery platform HCPC/DEX NPs with previously prepared carbon dots (CDs) as cross …
[HTML][HTML] Integrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living mice
Lipid nanocarriers are considered as promising candidates for drug delivery and cancer
targeting because of their low toxicity, biodegradability and capacity to encapsulate drugs …
targeting because of their low toxicity, biodegradability and capacity to encapsulate drugs …
In vivo fate of lipid-based nanoparticles
Highlights•LBNs are readily degradable through lipolysis by lipases.•LBNs that survive
lipolysis can be translocated to various organs and tissues.•Lipid composition, particle size …
lipolysis can be translocated to various organs and tissues.•Lipid composition, particle size …
In vivo fate of targeted drug delivery carriers
F Zhao, J Wang, Y Zhang, J Hu, C Li, S Liu… - International Journal …, 2024 - Taylor & Francis
This review aimed to systematically investigate the intracellular and subcellular fate of
various types of targeting carriers. Upon entering the body via intravenous injection or other …
various types of targeting carriers. Upon entering the body via intravenous injection or other …